Major Client Base
USA
Europe
USA Europe
|
|
Major Client Base USA Europe |
|
 |
 |
|
|
|
OUR PRODUCTS |
Active Pharma Ingredients | Pharma Intermediates | Under Developments |
|
PRODUCT SPECIFICATIONS |
Active Pharma Ingredients | Pharma Intermediates |
| PRODUCTS LIST | END USE | CAS NUMBER |
| 4 Aminobutyric Acid | Alendronate Sodium | 56-12-2 |
| Alendronic Acid | Alendronate Sodium | 66376-36-1 |
| Risedronic Acid | Risedronate Sodium | 105462-24-6 |
| Fluorescein Acid | Intermediate | 1461-15-0 |
| Janus Green B | Electro Plating | 2869-83-2 |
| Benzoin | Intermediate | 119-53-9 |
| Benzil | Intermediate | 134-81-6 |
| Benzilic Acid | Intermediate | 76-93-7 |
| Caproic Anhydride | Caproate Derivatives | 2051-49-2 |
| Enanthic Anhydride | Enanthate Derivatives | 626-27-7 |
| Gallic Acid | Gallate Derivative | 149-91-7 |
| Pyrogallol | Intermediate | 87-66-1 |
| 2,3,4-Trimethoxy Benzaldehyde | Trimetazidine | 2103-57-3 |
| 5 Chloro 4 Amino 2,1,3,benzothiadiazole | Tizanidine | 115398-34-0 |
| Ethylene Urea | Tizanidine | 120-93-4 |
| Acetyl Ethylene Urea | Tizanidine | 5391-39-9 |
| 4 Bromoaniline | Intermediate | 106-40-1 |
| Potassium Hydroxide (Powder) | Intermediate | 1310-58-3 |
| Silver Nitrate | Silver Derivatives | 7761-88-8 |
| PRODUCTS LIST | End Use | CAS Number |
| Fosphenytoin Sodium | Anti Epileptic | 92134-98-0 |
| Gabapentin | Anti Epileptic | 60142-96-3 |
| Lamotrigine | Anti Epileptic | 84057-84-1 |
| Glipizide | Anti Diabetic | 29094-61-9 |
| Ibandronate Sodium | Osteoporosis | 138926-19-9 |
| Pamidronate Disodium | Osteoporosis | 57248-88-1 |
|
OUR PRODUCTS |
Active Pharma Ingredients | Pharma Intermediates | Under Developments |
|
PRODUCT SPECIFICATIONS |
Active Pharma Ingredients | Pharma Intermediates |
Copyright
©, J P N Pharma Pvt. Ltd., All Rights Reserved